Pharmacy Focus

To open the episode, Erica Marini, PharmD, discussed a roundup of FDA and research updates in neurology. She covered the shifting accelerated-approval pathway for AMT-130 (uniQure), a gene therapy for Huntington disease, and a similar back-and-forth for a Hunter syndrome gene therapy. She also noted an expanded indication for olezarsen (Tryngolza; Ionis Pharmaceuticals) in severe hypertriglyceride...

Updated ASTCT infectious disease guidelines are reshaping how BMT and cellular therapy pharmacists approach prophylaxis, treatment thresholds, and drug–drug interactions across a range of opportunistic infections.

Find out more information about the Psychedelic Pharmacists Foundation (PPF) & Psychedelic Pharmacists Association (PPA): PPF: https://www.psychedelicpharmacistsfoundation.org/ PPA: https://psychedelicpharmacist.org/

The discussion examines the evidence behind common concerns about everyday products, food trends, and lifestyle habits, while emphasizing a practical, individualized approach to health and cancer prevention.

A panel of clinical pharmacists meets to discuss the complex process of operationalizing cell and gene therapy at an academic medical center.

In this episode of Mind the Meds , Erica Marini, PharmD, highlights information from the European Stroke Organization Conference include encouraging data on asundexian (Bayer), a factor XIa inhibitor showing reduced recurrent ischemic stroke risk without increased bleeding, as well as positive results from three trials of tirofiban in acute ischemic stroke settings. On the multiple sclerosis (MS)...

In this episode of Pharmacy Focus , moderator Bob Haight, PharmD, BCPP, AAPP Annual Meeting director and past president of American Association of Psychiatric Pharmacists (AAPP), discusses the AAPP 2026 Annual Meeting with Archana Jhawar, PharmD, BCPP, clinical assistant professor at the University of Illinois Chicago; and Chelsea Di Polito, PharmD, BCPP, psychiatric clinical pharmacist at the Uni...

You can connect with Marilyn Bulloch on LinkedIn here . Read more insights about hepatitis B throughout Hepatitis Awareness Month at Pharmacy Times' Hepatitis Resource Center . Episode Timestamps: 1:05: Introduction 2:08: Current Disease Burden of Hepatitis B 3:55: Risk Landscape for Adults 7:20: Link Between Chronic Hepatitis B and Liver Cancer 10:25: Expanded Vaccine Recommendations 13:25: The R...

When a cancer patient says "I've been doing some research," the conversation that follows can be just as complex as the treatment itself. In this episode, a malignant hematology clinical pharmacy specialist joins us to unpack health misinformation, AI-generated medical advice, wellness culture, and the controversial therapies oncology patients are bringing into the clinic — and how pharmacists can...

This inaugural episode of Mind the Meds introduces neurology pharmacy practice through a discussion between 3 neurology pharmacists working across inpatient and outpatient settings at the University of Utah. Host Erica Marini, PharmD , meets with her colleagues, Sarah Dahoney, PharmD , and Tyler Kenny, PharmD, BCCCP , both of whom are clinical pharmacists at the University of Utah Health, to discu...

Dr. JAM can be found on LinkedIn . Stay tuned for Pharmacy Times' coverage of APhA 2026 in LA. It can all be found here .

You can find more information about Derek Webb, PharmD, and Dennis Williams, PharmD, BCPS, AEC, below: Derek Webb on LinkedIn Dennis Williams on LinkedIn Dennis Williams Faculty Page - UNC Eshelman School of Pharmacy This content was independently developed by Pharmacy Times. While we acknowledge the support of our sponsor, all editorial decisions and opinions remain solely those of Pharmacy Times...

You can find more information about Derek Webb, PharmD, and Dennis Williams, PharmD, BCPS, AEC, below: Derek Webb on LinkedIn Dennis Williams on LinkedIn Dennis Williams Faculty Page - UNC Eshelman School of Pharmacy This content was independently developed by Pharmacy Times. While we acknowledge the support of our sponsor, all editorial decisions and opinions remain solely those of Pharmacy Times...

On Chen, MD, and Tahmid Rahman, MD discuss how plozasiran—an RNA-based APOC3-targeting therapy for patients with familial chylomicronemia syndrome with infrequent injections and a favorable safety profile—can transform care when integrated through coordinated multidisciplinary workflows with pharmacists leading patient identification, access, and monitoring.

You can find Dr. Joshi on LinkedIn here . Read more essential insights on PharmacyTimes.com .

William Van Decker, MD, discusses the key priorities of the upcoming ACC Legislative Conference, including telehealth, cardiovascular rehab, prior authorization reform, and the role of pharmacists in shaping patient-centered cardiovascular policy.

Lung cancer remains one of the leading causes of cancer-related death, yet many cases occur in people who have never smoked. One often-overlooked culprit is radon, a naturally occurring radioactive gas and the second leading cause of lung cancer.

How a new house bill could protect patient access after the IRA.